Medicare caps weight-loss drug costs at $50 monthly
#Medicare #WeightLossDrugsMedicare's pilot program will cover weight-loss drugs like Wegovy and Zepbound for $50 monthly starting July 1, offering cheaper access for eligible seniors. The temporary initiative runs through 2027, addressing high costs but raising future access concerns. read more
Medicare launches $50 monthly weight-loss drug coverage
#Medicare #WeightLossDrugsStarting July 1, Medicare will cover GLP-1 weight loss drugs like Wegovy and Zepbound for $50 monthly. Eligible seniors with obesity can access these treatments under a temporary pilot program through 2027, addressing high costs. read more
UPS invests $48 million in cold storage for weight-loss drugs
#WeightLossDrugs #UPSLogisticsUPS invests $48 million in 27 temperature-controlled facilities to meet rising demand for weight-loss drugs like GLP-1s, ensuring safe transport of sensitive medications. This expands cold-chain infrastructure across Americas, Europe, and Asia. read more
Medicare to Offer $50 Weight Loss Drugs Starting July
#Medicare #WeightLossDrugsStarting July 2026, Medicare's GLP-1 Bridge pilot offers eligible beneficiaries weight loss drugs like Wegovy for $50 monthly copay until Dec 2027. The program excludes low-income subsidies and doesn't count toward out-of-pocket caps. read more
Medicare Weight-Loss Drug Coverage Delayed
#Medicare #WeightLossDrugsThe Trump administration delays a Medicare pilot program to cover weight-loss drugs like Wegovy after insurers declined to participate. This postpones potential savings for millions, as the drugs can cost over $1,000 monthly without coverage. read more
FDA Approves Triple-Strength Wegovy for Weight Loss
#WeightLossDrugs #FDAApprovalThe FDA approved Wegovy HD, a weight-loss injection triple the previous dose. Patients lost an average of 21% body weight after 72 weeks. The higher-dose medication will be available in pharmacies starting in April. read more
Lilly Warns of Dangerous Impurity in Weight-Loss Compounds
#DrugSafety #WeightLossDrugsEli Lilly warns of health risks from compounded weight-loss drugs containing tirzepatide and vitamin B12. An unidentified impurity found in all tested samples poses unknown dangers. The company urges a nationwide recall and has notified the FDA. read more
McDonalds Targets Ozempic Users with New Menu
#FastFoodTrend #WeightLossDrugsMcDonald's is testing new protein-rich menu items to appeal to customers using weight-loss drugs like Ozempic, which suppress appetite. The chain joins others, including Smoothie King and Chipotle, in adapting to this growing health trend. read more
Weight-Loss Drugs Disrupt Food, Fashion, and Airlines
#WeightLossDrugs #EconomicImpactGLP-1 weight-loss drugs like Ozempic are reshaping industries beyond health. They reduce spending on groceries and fast food, lower alcohol consumption, and even cut airline fuel costs due to slimmer passengers, disrupting economic patterns. read more
Weight-Loss Drugs Reshape Food, Fashion, and Airlines
#WeightLossDrugs #EconomicImpactGLP-1 weight-loss drugs like Ozempic are reshaping industries beyond health. They reduce spending on groceries and fast food, lower alcohol consumption, cut airline fuel costs, and disrupt fashion retail, forcing widespread economic adaptation. read more
"Debate Over Anti-Obesity Jabs for Weight Loss Intensifies"
#AntiObesityJabs #WeightLossDrugsA US poll revealed 12% of respondents took anti-obesity jabs, with rising popularity. While effective for weight loss, risks include pancreatitis and gastrointestinal issues. Experts debate on its value in battling obesity, urging caution due to uncertainties over long-term effects and emphasizing the benefits of healthy lifestyle choices. read more
Biden proposal seeks to expand access to weight-loss injectables
#ObesityMedication #WeightLossDrugsMillions of obese Americans may access weight-loss drugs like Ozempic under a $35 billion Biden administration proposal awaiting Trump's approval. These injectables mimic GLP-1 hormone, aiding appetite regulation. Costly drugs could benefit millions on Medicaid and Medicare, though Trump's support remains uncertain. read more
"Biden Proposal to Cover Weight-Loss Drugs Raises Debate and Costs"
#MedicareCoverage #WeightLossDrugsThe Biden administration proposes Medicare coverage for weight-loss drugs like Wegovy for obese Americans, potentially costing $35 billion, sparking opposition by Robert F. Kennedy Jr. who advocates for healthier food and gym memberships. Debate looms on the effectiveness and cost of the drugs. read more
Obesity Rate Drops in US Adults; Weight-Loss Drugs May Help
#Obesity #WeightLossDrugsThe obesity rate for US adults slightly decreased from 41.9% (2017–2020) to 40.3% (2021–2023). Weight-loss drugs like GLP-1 agonists could be contributing to this drop, showing promise in enhancing other health conditions. read more
#Ozempic #WeightLossDrugs
FDA warns of overdoses related to Ozempic and other weight-loss drugs, specifically due to poor knowledge of drug measurements. Patients have experienced adverse effects from taking doses five to 20 times higher than intended. The FDA urges caution and proper administration. read more
#ToriSpelling #WeightLossDrugs
Tori Spelling, 51, stuns in a neon green bikini displaying a slim figure after using weight loss drugs. She tried Ozempic initially but later opted for Mounjaro to shed baby weight following her son's birth. read more
#WeightLossDrugs #GenericVersions
The emergence of generic versions of popular 'skinny jabs' like Ozempic, Wegovy, and Saxenda is expected to increase the availability and use of weight-loss drugs, creating a new boom in their usage worldwide. read more